Walid K. Chatila

46.8k total citations · 1 hit paper
50 papers, 878 citations indexed

About

Walid K. Chatila is a scholar working on Oncology, Pathology and Forensic Medicine and Cancer Research. According to data from OpenAlex, Walid K. Chatila has authored 50 papers receiving a total of 878 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Oncology, 21 papers in Pathology and Forensic Medicine and 21 papers in Cancer Research. Recurrent topics in Walid K. Chatila's work include Genetic factors in colorectal cancer (20 papers), Cancer Genomics and Diagnostics (20 papers) and Colorectal Cancer Treatments and Studies (12 papers). Walid K. Chatila is often cited by papers focused on Genetic factors in colorectal cancer (20 papers), Cancer Genomics and Diagnostics (20 papers) and Colorectal Cancer Treatments and Studies (12 papers). Walid K. Chatila collaborates with scholars based in United States, United Kingdom and Chile. Walid K. Chatila's co-authors include Nikolaus Schultz, Michael F. Berger, Barry S. Taylor, David B. Solit, Zsofia K. Stadler, Ahmet Zehir, Alison M. Schram, Gopa Iyer, Joshua Armenia and Philip Jonsson and has published in prestigious journals such as Nature Communications, Nature Genetics and Journal of Clinical Oncology.

In The Last Decade

Walid K. Chatila

42 papers receiving 872 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Genome doubling shapes the evolution and prognosis of advanced cancers

2018 343 citations Craig M. Bielski, Ahmet Zehir et al. Nature Genetics profile →

Peers

Walid K. Chatila

ONCOL

PRM

SURGE

Lucía Fanlo Spain

Juliann Shih United States

Demirkan Gursel United States

Linda Shyue Huey Chuang Singapore

Thomas Rio Frio France

Tord Jonson Sweden

Juan‐Han Yu China

Mary K. Washington United States

Yasuo Tohma Japan

Lucía Fanlo Spain

Walid K. Chatila

634 ×1.6

309 ×1.0

ONCOL

214 ×0.7

119 ×0.6

PRM

102 ×0.7

SURGE

Citations per year, relative to Walid K. Chatila Walid K. Chatila (= 1×) peers Lucía Fanlo

Countries citing papers authored by Walid K. Chatila

Since Specialization

Citations

This map shows the geographic impact of Walid K. Chatila's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Walid K. Chatila with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Walid K. Chatila more than expected).

Fields of papers citing papers by Walid K. Chatila

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Walid K. Chatila. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Walid K. Chatila. The network helps show where Walid K. Chatila may publish in the future.

Co-authorship network of co-authors of Walid K. Chatila

This figure shows the co-authorship network connecting the top 25 collaborators of Walid K. Chatila. A scholar is included among the top collaborators of Walid K. Chatila based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Walid K. Chatila. Walid K. Chatila is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Xie, Amy, Kelly R. Pekala, Kanika Arora, et al.. (2025). Meta-analysis reveals differences in somatic alterations by genetic ancestry across common cancers. Nature Genetics. 57(11). 2655–2660.

Cuevas-Navarro, Antonio, Emily G. Shuldiner, Walid K. Chatila, et al.. (2025). RIT1 Drives Oncogenic Transformation and Is an Actionable Target in Lung Adenocarcinoma. Cancer Research. 85(17). 3196–3206. 1 indexed citations

Manca, Paolo, Chin‐Tung Chen, Christina Y. Lee, et al.. (2025). Ultrasensitive ctDNA monitoring for organ preservation in patients with locally advanced rectal cancer. npj Precision Oncology. 10(1). 8–8.

Walch, Henry, Pranita Atri, Danny N. Khalil, et al.. (2025). Molecular and clinical determinants of targeted therapy (TT) outcomes in biliary tract cancer (BTC): Analysis of a prospectively maintained next generation sequencing (NGS) biorepository.. Journal of Clinical Oncology. 43(4_suppl). 555–555.

Keane, Fergus, Henry Walch, Joanne F. Chou, et al.. (2024). Molecular and Clinical Determinants of Acquired Resistance and Treatment Duration for Targeted Therapies in Colorectal Cancer. Clinical Cancer Research. 30(12). 2672–2683. 5 indexed citations

Foote, Michael B., James R. White, Walid K. Chatila, et al.. (2024). Analysis of Shared Variants between Cancer Biospecimens. Clinical Cancer Research. 31(2). 376–386.

Mondaca, Sebastián, Henry Walch, Nikolaus Schultz, et al.. (2024). Clinical and Genomic Characterization of ERBB2 -Altered Gallbladder Cancer: Exploring Differences Between an American and a Chilean Cohort. JCO Global Oncology. 10(10). e2400090–e2400090. 1 indexed citations

Kemel, Yelena, James W. Smithy, Diana Mandelker, et al.. (2024). Germline pathogenic variants in a large convenience cohort of multiple melanoma subtypes.. Journal of Clinical Oncology. 42(16_suppl). 9595–9595. 1 indexed citations

Mastrogiacomo, Brooke, Cameron N. Fick, Yuan Liu, et al.. (2024). Abstract 2556: Longitudinal analyses of clinical sequencing data provide novel insights into the evolutionary dynamics of lung adenocarcinoma. Cancer Research. 84(6_Supplement). 2556–2556. 1 indexed citations

10.

Foote, Michael B., Henry Walch, Yelena Kemel, et al.. (2023). The Impact of Germline Alterations in Appendiceal Adenocarcinoma. Clinical Cancer Research. 29(14). 2631–2637. 2 indexed citations

11.

Tagore, Mohita, Nelly M. Cruz, Laura Menocal, et al.. (2023). GABA Regulates Electrical Activity and Tumor Initiation in Melanoma. Cancer Discovery. 13(10). 2270–2291. 24 indexed citations

12.

Özer, Muhammet, Nicolas Lecomte, Juan M. Schvartzman, et al.. (2022). Concurrent GermlineBRCA1/2and Mismatch Repair Mutations in Young-Onset Pancreatic and Colorectal Cancer: The Importance of Comprehensive Germline and Somatic Characterization to Inform Therapeutic Options. JCO Precision Oncology. 6(6). e2100560–e2100560. 3 indexed citations

13.

Gorelick, Alexander N., Minsoo Kim, Walid K. Chatila, et al.. (2021). Respiratory complex and tissue lineage drive recurrent mutations in tumour mtDNA. Nature Metabolism. 3(4). 558–570. 58 indexed citations

14.

Yaeger, Rona, Viktoriya Paroder, ‬David D. B. Bates, et al.. (2020). Systemic Chemotherapy for Metastatic Colitis-Associated Cancer Has a Worse Outcome Than Sporadic Colorectal Cancer: Matched Case Cohort Analysis. Clinical Colorectal Cancer. 19(4). e151–e156. 8 indexed citations

15.

Mondaca, Sebastián, Henry Walch, Subhiksha Nandakumar, et al.. (2020). Specific Mutations in APC, but Not Alterations in DNA Damage Response, Associate With Outcomes of Patients With Metastatic Colorectal Cancer. Gastroenterology. 159(5). 1975–1978.e4. 27 indexed citations

16.

Won, Elizabeth, Walid K. Chatila, Jaclyn F. Hechtman, et al.. (2019). Efficacy of Combined VEGFR1-3, PDGFα/β, and FGFR1-3 Blockade Using Nintedanib for Esophagogastric Cancer. Clinical Cancer Research. 25(13). 3811–3817. 14 indexed citations

17.

Greally, Megan, Joanne F. Chou, Walid K. Chatila, et al.. (2019). Clinical and Molecular Predictors of Response to Immune Checkpoint Inhibitors in Patients with Advanced Esophagogastric Cancer. Clinical Cancer Research. 25(20). 6160–6169. 75 indexed citations

18.

Smith, J. Joshua, Walid K. Chatila, Francisco Sánchez-Vega, et al.. (2019). Genomic stratification beyond Ras/B‐Raf in colorectal liver metastasis patients treated with hepatic arterial infusion. Cancer Medicine. 8(15). 6538–6548. 8 indexed citations

19.

Bielski, Craig M., Ahmet Zehir, Alexander Penson, et al.. (2018). Genome doubling shapes the evolution and prognosis of advanced cancers. Nature Genetics. 50(8). 1189–1195. 343 indexed citations breakdown →

20.

Mondaca, Sebastián, Walid K. Chatila, ‬David D. B. Bates, et al.. (2018). FOLFCIS Treatment and Genomic Correlates of Response in Advanced Anal Squamous Cell Cancer. Clinical Colorectal Cancer. 18(1). e39–e52. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact